D. E. Shaw & Co., Inc. - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607AB6. A total of 26 filers reported holding SAREPTA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
D. E. Shaw & Co., Inc. ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$19,645,113
+52.4%
11,089,000
+45.8%
0.02%
+61.5%
Q2 2023$12,886,582
+62.0%
7,606,000
+85.5%
0.01%
+44.4%
Q1 2023$7,953,192
-69.9%
4,100,000
-71.0%
0.01%
-69.0%
Q4 2022$26,436,157
+12.2%
14,147,0000.0%0.03%
+3.6%
Q3 2022$23,564,000
-36.0%
14,147,000
-51.5%
0.03%
-34.9%
Q2 2022$36,798,000
-18.1%
29,192,000
-14.7%
0.04%
+2.4%
Q1 2022$44,903,000
-23.9%
34,217,000
-14.9%
0.04%
-14.3%
Q4 2021$59,031,000
-13.0%
40,217,000
-12.0%
0.05%
-19.7%
Q3 2021$67,840,000
-0.0%
45,717,000
-10.7%
0.06%
+3.4%
Q2 2021$67,871,000
+13.8%
51,217,000
+12.0%
0.06%
+1.7%
Q1 2021$59,629,000
-32.8%
45,717,000
+26.2%
0.06%
-26.6%
Q4 2020$88,701,000
+26.8%
36,217,000
+7.3%
0.08%
+9.7%
Q3 2020$69,965,000
+48.5%
33,744,000
+64.6%
0.07%
+28.6%
Q2 2020$47,128,00020,500,0000.06%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
DeepCurrents Investment Group LLC 53,865,000$101,127,2803.93%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 88,657,000$165,397,6133.42%
Boussard & Gavaudan Investment Management LLP 11,898$21,871,5382.42%
TENOR CAPITAL MANAGEMENT Co., L.P. 38,394,000$71,834,2261.71%
WOLVERINE ASSET MANAGEMENT LLC 79,876,000$149,367,3841.55%
CSS LLC/IL 4,747,000$8,868,6060.50%
Opti Capital Management, LP 3,000,000$5,611,9380.48%
Verition Fund Management LLC 16,459,000$30,786,5600.48%
Aequim Alternative Investments LP 5,000,000$9,352,5000.25%
MIZUHO SECURITIES USA LLC 1,097,000$2,047,6160.19%
View complete list of SAREPTA THERAPEUTICS INC shareholders